B. Braun Introduces Next Generation Safety-Engineered Catheter
Hosts INS 2012 Exhibitor Theater featuring Lynn Hadaway discussing occupational safety and the improvements to reduce needlestick injury and blood exposure.
Bethlehem, PA – April 26, 2012 − B. Braun Medical Inc. (B. Braun) will attend INS 2012 with their latest development in safety-engineered medical devices, the Introcan Safety® 3 Closed IV Catheter. The new product includes the proven passive protection from needlestick injuries that has made B. Braun the U.S. leader in passive safety-engineered IV catheters. Advancements in the new Introcan Safety® 3’s design include the unique multi-access blood control septum to protect healthcare professionals from blood exposure and an integrated stabilization platform that helps to improve catheter stability and minimize movement within the vessel. “Recent research 1 confirms passive safety engineered devices are most effective for needlestick injury prevention,” said Tom Sutton, Vice President, Vascular Access and IV Systems for B. Braun Medical Inc. “The Introcan Safety® 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control septum to aid in the prevention of blood exposure each time the device is accessed.”
The company will also host two Exhibitor Theater Sessions featuring Lynn Hadaway, M.Ed, RN, BC, CRNI discussing “Mucocutaneous Blood Exposure and Peripheral Catheters, Acknowledging the Risk, Documenting Occurrences.” With over thirty-five years of experience in infusion nursing and adult education, Hadaway’s expertise has been published on topics ranging from vascular access devices, anatomy and physiology, to infusion therapy and vascular access complication management. She is a champion for advanced practices and devices that protect healthcare professionals and patients. Sutton will follow Hadaway’s presentation to discuss “New Product Technology from B. Braun.”
Sutton says conferences like INS 2012 are important. “Members of INS are committed advocates that influence change to improve patient care,” Sutton says. “We hope that the clinicians who visit our booth and Exhibitor Theater events will return to their individual care settings with valuable information that increases safety and positive patient outcomes.” Presentations will be on Monday, April 30 at Exhibitor Theater A (Rio Pavilion, 200 Aisle) and at Exhibitor Theater B (Rio Pavilion, 600 Aisle) on Tuesday May 1. Both Exhibitor Theater sessions will run from 11:10 am until noon. B. Braun’s broad line of peripheral IV catheters, infusion systems, luers, stopcocks, accessory and kits will be demonstrated at Booth 315.
About B. Braun
B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company’s “Sharing Expertise®” philosophy, B.Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians
reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.
Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at firstname.lastname@example.org or visit B. Braun at http://www.bbraunusa.com.
1 Needlestick Injury Rates According to Different Types of Safety-Engineered Devices: Results of a French Multicenter Study conducted by GERES (Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux), and published by Infection Control and Hospital Epidemiology, April 2010; 31:402-407